Biotechnology, or biotech, and its applications are evolving at breakneck speed – revolutionizing industries, including medicine, agriculture, energy and chemical and materials through the creation of products and processes that have never before existed.
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require updates to product labeling regarding serial testing.
Passed in 2020 and effective Jan. 1, 2022, the No Surprises Act contains provisions that protect people from surprise medical billing and out-of-network emergency care costs not reimbursed by insurance.
Leaders of the state’s biggest hospital systems and insurers jousted Wednesday about how to manage the increasing costs of health care at a time when historic staffing shortages are threatening people's access to care. Dr. Anne Klibanski, the chief executive of Mass General Brigham, told the Massachusetts Health Policy Commission that hospitals are inundated with sick patients, and severely short on staff to care for them.
Through the Medicare Advantage Value-Based Insurance Design (VBID) Model, the Centers for Medicare and Medicaid Services (CMS) is currently testing a broad array of innovations designed to reduce Medicare program expenditures, enhance the quality of healthcare for Medicare beneficiaries, and improve the coordination and efficiency of healthcare service delivery.
The parent company of Blue Cross and Blue Shield of Minnesota is selling Livio Health, a business that provides in-home health services to seniors. Livio will be acquired by Lifespark, a St. Louis Park-based company with a technology platform for helping seniors avoid trips to the hospital.
